Citi Pharma Limited (PSX:CPHL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
84.16
-0.32 (-0.38%)
At close: Feb 27, 2026
-14.77%
Market Cap 19.23B
Revenue (ttm) 14.10B
Net Income (ttm) 1.04B
Shares Out 228.46M
EPS (ttm) 4.55
PE Ratio 18.50
Forward PE 20.04
Dividend 3.50 (4.16%)
Ex-Dividend Date Oct 17, 2025
Volume 1,228,265
Average Volume 2,785,583
Open 83.75
Previous Close 84.48
Day's Range 82.60 - 85.61
52-Week Range 60.50 - 105.31
Beta 0.44
RSI 45.95
Earnings Date Feb 13, 2026

About Citi Pharma

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Its product portfolio includes capsules, tablet, syrup drops, ointment, sachet, and formulation. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan. [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 2012
Employees 531
Stock Exchange Pakistan Stock Exchange
Ticker Symbol CPHL
Full Company Profile

Financial Performance

In fiscal year 2025, Citi Pharma's revenue was 13.15 billion, an increase of 6.00% compared to the previous year's 12.41 billion. Earnings were 892.04 million, an increase of 7.03%.

Financial Statements

News

There is no news available yet.